105 related articles for article (PubMed ID: 1319891)
21. On some glycosidases (beta-D-mannosidase, alpha-L-fucosidase, N-acetyl-beta-D-glucosaminidase) of human seminal plasma.
Ben Ayed S; Gonzales J; Foglietti MJ; Percheron F; Bernard M
Andrologia; 1989; 21(5):432-6. PubMed ID: 2817447
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
24. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
Yu ZW; Duan FL; Yang XW
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
[TBL] [Abstract][Full Text] [Related]
26. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.
Yamashita K; Taketa K; Nishi S; Fukushima K; Ohkura T
Cancer Res; 1993 Jul; 53(13):2970-5. PubMed ID: 7686446
[TBL] [Abstract][Full Text] [Related]
27. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
[TBL] [Abstract][Full Text] [Related]
29. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
30. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum glycosidases in gynecologic cancer patients.
Chamut S; Japaze H; de Martínez NR
Medicina (B Aires); 1980; 40(2):151-5. PubMed ID: 7412546
[No Abstract] [Full Text] [Related]
32. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M
Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021
[TBL] [Abstract][Full Text] [Related]
33. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
34. Glycosyltransferase and glycosidase activities in ovarian cancer patients.
Chatterjee SK; Bhattacharya M; Barlow JJ
Cancer Res; 1979 Jun; 39(6 Pt 1):1943-51. PubMed ID: 445394
[TBL] [Abstract][Full Text] [Related]
35. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
[TBL] [Abstract][Full Text] [Related]
36. Markers for hepatocellular carcinoma.
Wu AH; Sell S
Immunol Ser; 1990; 53():403-22. PubMed ID: 1713067
[TBL] [Abstract][Full Text] [Related]
37. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
Xu K; Meng XY; Wu JW; Shen B; Shi YC; Wei Q
Am J Gastroenterol; 1992 Aug; 87(8):991-5. PubMed ID: 1353662
[TBL] [Abstract][Full Text] [Related]
39. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
40. Decreased serum beta-D-mannosidase activity in diabetic patients, in comparison with other glycosidases.
Bernard M; Brochet C; Percheron F
Clin Chim Acta; 1985 Oct; 152(1-2):171-4. PubMed ID: 4053398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
